|
|
|
Sunday, March 18, 2012 — 1:30 p.m.
|
- The Origins of Ovarian Cancer Part 1 - Serous Tumors
|
|
Moderators:
|
C. Simon Herrington, University of Dundee, Dundee, Scotland, UK, and C. Blake Gilks, Vancouver General Hospital, Vancouver, BC, Canada
|
| Putative Precursor Lesions of High—grade Serous Carcinoma Including STIC, p53 Signature and SCOUT - Christopher P. Crum, Brigham and Women's Hospital, Boston, MA |
| Putative Precursor Lesions of Low—grade Ovarian Serous Tumors Including Endosalpingiosis and Noninvasive Implants - Robert Kurman, Johns Hopkins University School of Medicine,Baltimore, MD |
| Developments in the International Society of Gynecological Pathologists - C. Simon Herrington, University of Dundee, Dundee, Scotland, UK |
| The Mullerian Origin of Ovarian Tumors - Elvio Silva, University of Texas and M.D. Anderson Cancer Center, Houston, TX |
| The Clinical Implications of Recent Thinking on the Origin of Pelvic Serous Carcinoma - Dianne Miller, British Columbia Cancer Agency, Vancouver, BC, Canada |
|
|
|